Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021


HomePromega CorporationPromega Launches Wizard® HMW DNA Extraction Kit Ahead of 2020

Promega Launches Wizard® HMW DNA Extraction Kit Ahead of 2020

Promega Corporation, a global biotechnology manufacturer, today launched its new Wizard® HMW DNA Extraction Kit for researchers working with large fragments of genomic DNA. The kit, as demonstrated in a poster presented at this week’s 2020 Advances in Genome Biology and Technology (AGBT) meeting, enables researchers to obtain DNA that will provide strong performance in long-read sequencing applications in a 90-minute manual protocol.

“We’ve worked with a lot of our customers and collaborators to develop a workflow where we’re able to get read lengths of 500kb in some of these new sequencing technologies, and it’s really enabled some of their research,” says Promega Research & Development Scientist Douglas Horejsh. “If you’re looking at an organism that’s never been sequenced or dealing with structural variations and rearrangements within the genome, it’s very difficult to take short reads to come up with a large sequence. A lot of workflows out there have been designed to purify smaller nucleic acids, but the Kit is able to get us up to 300kb and higher.”

Compared to leading competitors, the Wizard® HMW DNA Extraction Kit purifies a significantly higher proportion of fragments over 125kb. In long-read sequencing, the DNA from the Promega kit produced very long maximum reads and high N50 values, which indicates a higher proportion of large fragments in the sample.

The kit supports purification from a variety sample type including whole blood, bacterial cultures, cultured mammalian cells, and plant leaf tissue. It joins an existing portfolio of both manual and automated kits to extract a variety of nucleic acids from a broad range of sample types.

The kit is not for diagnostic use.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy